Intuit Inc Expands Enterprise Suite to Target MidMarket Business Growth Charles Schwab CEO Prioritizes Wealth Building Over Speculative Trends to Drive Customer Growth Bitcoin Dips Below 76000 as Market Faces Weekly Loss Amid Liquidations and Rate Uncertainty April Jobs Report Expected to Show Cooling Yet Resilient Labor Market ATT CEO Highlights Growing Demand for Skilled BlueCollar Workers in AIDriven Economy Indian Billionaires Accelerate Overseas Acquisitions as Domestic Growth Moderates ZS Q1 2026 Earnings EPS Surprises to the Upside Amidst Growth Focus QH Q4 2021 Earnings Staggering EPS Miss Exposes Deep Operational Challenges HIG Q1 2026 Earnings Profit Falls Short of Estimates Shares Flat Diamond Hill Investment Group Inc DHIL Q1 2025 Earnings Solid EPS Report Amid Quiet Market Reaction CLB Q1 2026 Earnings EPS Miss Weighs on Results Stock Gains Despite Disappointing Profitability PPL Q1 2026 Earnings EPS Beats Estimates Utility Operations Drive Steady Performance Talkspace Consolidates Near Support as TALK Holds at 519 Champion Homes SKY Rallies 208 as Builders Sector Momentum Builds Nuveen Municipal Credit Opportunities Fund NMCO Edges Higher Amid Steady Income Demand Charles Schwab SCHW Holds Steady Near Support Amid Modest Decline PagerDuty PD Breaks Above Recent Range After 348 Surge Nvidia Earnings Reveal 200 Billion Edge Computing Opportunity Amid China Market Shift CALX Q1 2026 Earnings EPS Matches Estimates Stock Rises 211 Amphastar Pharmaceuticals AMPH Gains 138 as Stock Consolidates Near Key Resistance MSGS Q1 2026 Earnings EPS Falls Well Below Estimates as Stock Holds Steady Almonty Industries Q1 2026 Earnings EPS Misses Estimates as Loss Widens Shares Decline Redwood Trust Inc 900 Senior Notes Due 2029 RWTO Q1 2026 Earnings BottomLine Miss Underscores NearTerm Headwinds SFL Q1 2026 Earnings Stunning EPS Surprise of 1880 Despite Negative Stock Reaction Rocket Pharmaceuticals Inc RCKT Q1 2026 Earnings Clinical Progress Overshadowed by Slight EPS Miss and Capital Concerns OLLI Q1 2026 Earnings EPS Slightly Misses Estimates as Stock Dips OnKure Therapeutics OKUR Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline